A Few Things with Jim Barrood

We discussed a number of things including:

1. How small businesses are responding during crisis

2. What strategies can entrepreneurs implement now

3. What support programs can they take advantage of

Panelists:

Susan Scherreik, Founding Director, Center for Entrepreneurial Studies, Stillman School of Business, Seton Hall University

Susan joined Seton Hall University in 2003 as the Founding Director of the Stillman School of Business Center for Entrepreneurial Studies. She created the Seton Hall University Entrepreneur Hall of Fame, the $16K Pirates Pitch Startup contest, and the Pirates Pitch for High School Students contest, which offers $50K in scholarships and prizes. Most recently, Scherreik launched the Pirates Launch Pad summer accelerator program and Seton Hall’s summer Entrepreneur Boot Camp. She was named a Top 25 Leading Woman Entrepreneur of NJ in 2016. She was a judge in the EY Entrepreneur of Year Comp./NJ for seven years. Scherreik is the founder of UPitchNJ, a statewide business competition that involves 14 NJ universities.

Suresh Kumar, Professor of Practice and Director of Innovation & Entrepreneurship Programs, Ying Wu College of Computing, New Jersey Institute of Technology

Suresh is a Deloitte Fast 50 and 5-time INC 500 ranked serial entrepreneur, who is also immersed in academics and policy development in entrepreneurship. He has a doctoral degree in the area of high-growth immigrant entrepreneurship and is an expert in the Lean Startup methodology for scaling startups and in the area building sustainable innovation and economic ecosystem builder. Most recently he served as a member of the Small Business and Entrepreneurship sub-committee of the Joe Biden campaign. Currently, Suresh serves as Professor of innovation and entrepreneurship at New Jersey Institute of Technology.

Dale Caldwell, Executive Director, Rothman Institute of Innovation and Entrepreneurship, Fairleigh Dickinson University

Dr. Caldwell is a professor and the executive director of the Rothman Institute of Innovation and Entrepreneurship in the Silberman College of Business at Fairleigh Dickinson University (FDU). He is leading the Institute’s efforts to support, promote and research family, veteran and student entrepreneurship. In addition, Dr. Caldwell is the host of the TV show Family Business World (www.FamilyBusinessWorld.com). His research focus is on entrepreneurship, job creation and public policy. Dr. Caldwell’s professional experience includes being the CEO of the management consulting firm Strategic Influence LLC, senior manager at Deloitte Consulting, founding executive director of the Newark Alliance and deputy commissioner of the New Jersey Department of Community Affairs.

Anne-Marie Maman, Executive Director, Princeton Entrepreneurship Council, Princeton University Anne-Marie is the Executive Director of Princeton Entrepreneurship Council.

PEC works to engage and educate Princeton-connected entrepreneurs of all levels, both on campus and in locations around the world. We focus on collaborative programming, mentoring and funding in a way that educates, engages and inspires. Our portfolio includes multiple conferences, an advisory platform for entrepreneurs seeking guidance, a seed venture fund, alumni/faculty forum, networking sessions, a wetlab/drylab incubator, and educational programming for faculty, grad student and postdocs. PEC also supports Princeton University in its outreach to the local entrepreneurial ecosystem. Anne-Marie is an entrepreneur who founded three companies; one improving bedside catheter placements, one detecting early signs of hemorrhagic shock, and the third working in real-time detection of bacteria.

On June 27, 2024 we discussed AI in Life Sciences with Jot Chahal, Johnson & Johnson, Patricia Leuchten, Diligent Pharma and V. "Bala" Balasubramanian, PhD, MBA, Orion Innovation

Jot Chahal is Vice President, Global Digital Health at Johnson & Johnson Innovative Medicine, where he is accelerating the commercialization of digital health assets across the pharmaceutical business.

Partnering with our regions, technology, and R&D leaders across the globe to build digital health (SaMD, DTx) capabilities and drive business growth across all therapy areas.

He is an entrepreneurial and results-driven health technology executive with twenty years of experience in driving top-line profitable growth through innovation, and data-driven strategies across industries, services, and markets globally.

Patti Leuchten is a pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions.

In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent Qualification Platform.

Dr. V. “Bala” Balasubramanian is currently SVP and Global Head of Industry Solutions Group for Healthcare and Life Sciences at Orion Innovation.

He is responsible for defining the GTM strategy, solution and service offerings for the HLS division, exploring digital transformation initiatives to further the needs of clients, and providing thought leadership to the industry.

It has resulted in Orion being featured in Gartner and Everest Peak Matrix Benchmark Reports in 2022 and 2023. He has recently written about opportunities and challenges with respect to GenAI in Life Sciences.

Prior to Orion, Bala was the Co-Founder and CEO of Cabeus where he was responsible for strategy, leadership and vision for both service offerings and a cloud platform to transform the regulatory value chain for Life Sciences.

#ai #drugdiscovery #clinicaltrials

#podcast #AFewThingsPodcast

We discussed a number of things including:

1. Valley Health's response to the COVID-19 crisis

2. How this pandemic has created an extraordinary opportunity for innovation and learning

3. The use of AI in tracking data related to pandemic infections and patients

4. How the virus has affected Dr. Brenner personally - symptoms and recovery

Dr. Brenner is the President of Clinical Integration and Physician Enterprise for Valley Health System (VHS). He oversees quality and performance improvement, strategic relations and clinical service line development across VHS, as well as Valley Medical Group, Valley Home Care, ColigoCare (VHS’s 600-provider Clinically Integrated Network) and Population Health.

Dr. Brenner joined Valley in 2015 as SVP and Chief Physician Executive for VHS, and has led an organizational transformation from Fee-For-Service to Fee-For-Value that included the conversion to shared savings contracts and the development of ColigoCare and VHS’s Population Health Department. Dr. Brenner led the creation of service lines spanning the continuum of care, the reorganization of Transitions in Care and Case Management, and the unification of quality management across VHS. Prior to joining VHS, Dr. Brenner served as Chief Medical Officer (CMO) of Summit Medical Group for nine years and, subsequently, as CMO of Summit Health Management.

In those roles, he was responsible for strategic expansion; enhancement of organizational performance, patient safety and patient experience through the creation of robust population health, risk management and advocacy departments; clinical program development and advancement of clinical information technology. Prior to that position, he was a Senior Executive at Mountainside Hospital/Atlantic Health System and served as the Chairman of the Family Medicine Department. Dr. Brenner has also spent 15 years in graduate medical education, the last seven of which he served as the Family Medicine Residency Director at Mountainside Hospital/Atlantic Health System.

------

Simon Samaha, MD, MBA, is a veteran healthcare executive and entrepreneur. He is currently a Senior Advisor at Oliver Wyman and a member of its Health and Life Sciences Team. He is a recognized thought leader in provider with deep expertise in Clinical Services and Physician Enterprises.

His career started as an executive (including serving as CEO at Summit Medical Group) on the provider side in both not and for profit, later joining a top global consulting firm initially as their healthcare center cluster leader (serving Europe Africa, India and Middle East) and later leading the Clinical Transformation practice. Dr. Samaha's focus is on strategic clinical transformation, assisting organization in optimizing their clinical assets and engaging their physicians in these transformation journeys.

He has deep expertise in all aspects of physician organizations including M&A, VBC, network development, operational and financial optimization, and service line design and implementation. Dr. Samaha also helps lead Kentan Staffing Solutions, the healthcare division of ICS. He plays a key role in defining the client needs and is personally involved in reviewing every clinical SME.

We discussed a number of things including:

1. His experience transforming his March 21st Social Media into a successful virtual event

2. How to leverage social media platforms and digital tools to achieve mission

3. General advice for nonprofit leaders and organizations in these challenging times

4. Took answers to your questions

Sree is the inaugural Marshall Loeb Visiting Professor of Digital Innovation at Stony Brook School of Journalism. During the Covid19 crisis, he's hosting a daily global conversation with experts: http://bit.ly/sreecovid19call

Sree is a leading social and digital media consultant and trainer, working with nonprofits, startups, companies and executives around the world. He has served as Chief Digital Officer of New York City, the Metropolitan Museum of Art and Columbia University (where he was a full-time professor of journalism for 20+ years). He has also been a paid on-air tech expert for the three largest news stations in NYC.

He taught a course on entrepreneurship at Columbia for four years with Ken Lerer, the co-founder of Huffington Post, chairman of Buzzfeed and co-founder of venture firm LererHippeau. Sree is the creator of three popular social media learning opportunities that have been attended by thousands of attendees in NYC, several U.S. cities and more than a dozen countries: Social Media Weekend, Social Media Day and Social Media One-Night Stand. Join Sree's Sunday Note newsletter with tech, social and life tips: http://bit.ly/sreenote. And join his FB Group, Sree's Advanced Social Media: http://bit.ly/sreefbadvanced

In 2015, Fast Company named him one of the 100 most creative people in business and in 2010, he was named one of the 35 most influential people in social media by the Poynter Institute. In 2014, he was named most influential CDO by CDO Club.

His new NYT guide to social media: http://bit.ly/nyt2017

His social media FB group: http://bit.ly/sreefbadvanced

His five TEDx talks: http://bit.ly/sreetedxvideos.

Twitter: @sree: http://twitter.com/sree

Email: [email protected]

We discussed a number of things including:

1. How to lead in a time of great uncertainty

2. Raising funds and managing teams during a downturn

3. What he's seeing in biotech and biopharma sectors

Francois Nader, MD, is a leading value builder in the biopharma industry. Dr. Nader currently serves as chairman of Acceleron Pharma (XLRN), Prevail Therapeutics (PRVL) and Talaris Therapeutics; and board director of Alexion Pharmaceuticals (ALXN) and Moderna (MRNA). Previously, Dr. Nader was President, Chief Executive Officer and Executive Director of NPS Pharma from 2008 to 2015.

During his tenure as CEO, Dr. Nader transformed NPS Pharma into a leading global biotechnology company focused on delivering innovative therapies to patients with rare diseases. The company was acquired by Shire for $5.2B in 2015. Dr. Nader won the Ernst and Young National Life Science Entrepreneur of the Year® award in 2013. Before NPS, Dr. Nader was a venture partner at Care Capital.

Prior, he served on the North America Leadership Team of Aventis and its predecessor companies holding a number of executive positions including senior vice-president, integrated healthcare markets and North America medical and regulatory affairs. Previously, he led the global commercial operations at the Pasteur Vaccins’ division of Rhone-Poulenc.

Dr. Nader is past chairman of BioNJ, New Jersey’s biotechnology trade organization and has served on the board of the Biotechnology Industry Organization (BIO) and as independent director of Clementia Pharmaceuticals (CMTA) acquired by IPSEN for $1.2B in 2019, Advanced Accelerator Applications (AAAP) acquired by Novartis for $3.9B in 2018, Baxalta (BXLT) acquired by Shire for $32B in 2016, Trevena (TRVN) and Noven (NOVN) acquired by Hisamitsu for $459M in 2009.

Dr. Nader earned his French Doctorate in Medicine from St. Joseph University (Lebanon) and his Physician Executive MBA from the University of Tennessee.